TOP TIERMARKET NEWSWIRE
News & sentiment

GAIN THERAPEUTICS IN (GANX) — News & AI sentiment

GAIN THERAPEUTICS IN (GANX) news roundup. 5 stories in the past week, 7 over 30 days. Average 30-day sentiment is 53/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
5
avg sentiment 53/100
30d stories
7
avg sentiment 53/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

GANX news in the last 24 hours, 7 days, 30 days and 90 days

How much GANX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowGANX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days553/100GANX headlines →
Last 30 days753/100GANX headlines →
Last 90 days2155.6/100GANX headlines →

Latest stories on GANX

1d ago
3d ago
3d ago
Gain Therapeutics GAAP EPS of -$0.07 beats by $0.05
Seeking Alpha63 · neutralearnings
3d ago
4d ago
Nov 5
Gain Therapeutics, Inc. (GANX) files 8-K
SEC 8-K50 · neutralgeneral
Oct 28
Oct 8
Oct 8
BTIG reiterates Buy on Gain Therapeutics stock on trial data
Investing.com Analyst Ratings61 · neutralanalyst
Oct 5
Oct 1
Oct 1
Gain Therapeutics, Inc. (GANX) files 8-K
SEC 8-K50 · neutralgeneral
Oct 1
Sep 29
Sep 29
Gain Therapeutics Names CEO as Interim CFO
TipRanks50 · neutralgeneral
Sep 28
Gain Therapeutics, Inc. (GANX) files 8-K
SEC 8-K50 · neutralgeneral
Sep 28
Sep 17
Sep 17
H.C. Wainwright reiterates Gain Therapeutics stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Aug 25
Gain Therapeutics, Inc. (GANX) files 8-K
SEC 8-K50 · neutralgeneral
Aug 11
Aug 11
Gain Therapeutics GAAP EPS of -$0.11 beats by $0.03
Seeking Alpha56 · neutralearnings
Aug 11
Aug 11
Open GANX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →